2023
|
Invention
|
Piperidine derivatives as hdac1/2 inhibitors.
Provided herein are compounds, pharmaceutical comp... |
2021
|
Invention
|
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neur... |
|
Invention
|
Piperidine derivatives as hdac1/2 inhibitors. Provided herein are compounds, pharmaceutical compo... |
2020
|
Invention
|
Hdac inhibitors for the treatment of diabetic peripheral neuropathy.
The invention relates to HD... |
|
Invention
|
Substituted piperazines as selective hdac1,2 inhibitors. Provided herein are compounds of Formula... |
2019
|
Invention
|
Pyrimidine and pyrazine hdac1,2 inhibitors.
Provided herein are compounds, pharmaceutical compos... |
|
Invention
|
Pyrimidine and pyrazine hdac1,2 inhibitors. Provided herein are compounds, pharmaceutical composi... |
|
Invention
|
Hdac1,2 inhibitors. Provided herein are compounds, pharmaceutical compositions comprising such co... |
2018
|
Invention
|
Hdac inhibitors for the treatment of diabetic peripheral neuropathy. The invention relates to HDA... |
2017
|
Invention
|
Piperazine derivatives as selective hdac1,2 inhibitors. Provided herein are compounds of formula ... |
|
Invention
|
Selective hdac1 and hdac2 inhibitors. Provided herein are compounds, pharmaceutical compositions ... |
|
Invention
|
Hdac1/2 inhibitors for the treatment of neurodegenerative and/or cognitive disorders.
Provided h... |
|
Invention
|
Hdac1/2 inhibitors for the treatment of neurodegenerative and/or cognitive disorders. Provided he... |
2016
|
Invention
|
Selective hdac3 inhibitors. Provided herein are HDAC3 inhibitors, as well as methods of treatment... |
|
Invention
|
Treatment of neuroblastoma with histone deacetylase inhibitors.
Provided herein are combinations... |
2015
|
Invention
|
Pyrimidine hydroxy amide compounds for treating peripheral neuropathy.
The invention relates to ... |
|
Invention
|
Induction of gata2 by hdac1 and hdac2 inhibitors.
Provided herein are compounds, pharmaceutical ... |
2014
|
Invention
|
Selective hdac3 inhibitors. Provided herein are inhibitors of HDAC3, as well as methods of treatm... |